Archive 1995–2023
2004, volume 20, issue 3
Article
Do novel research on stress and depression change our opinion about mechanism of action of antidepressants?
Wojciech Kostowski
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 267-278
Article
The usefulness of the debrisoquine test in evaluating the efficacy and safety of treatment with antidepressants
Koszewska I., Bidziński A., Turzyńska D., Kalinowski A., Święcicki Ł., Dąbrowski M., Torbiński J., Burna-Drażkowic E., Fornal S., Grądzka D., Namysłowska M., Pużyński S., Płaźnik A.
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 279-292
Article
Pharmacological treatment for aggressive patients with psychiatric disorders
Małgorzata Rzewuska
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 293-323
Article
Mood-normalizing action of lamotrigine
Maryla Tuszewska, Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 325-334
Article
Aripiprazol (Abilify), an antipsychotic with a novel mechanism of action, the first dopamine-serotonin system stabilizer
Małgorzata Rzewuska
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 335-349
Article
Switching of atypical neuroleptics in hospitalized patients
Bartosz Łoza, Mariusz Bartyzel
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 351-366
Article
The effects of adjunctive donepezil treatment to new atypical neuroleptics (risperidone, and olanzapine) on mental and cognitive state of schizophrenic patients
Jolanta Rabe-Jabłońska, Krzysztof Jęczkowski, Anna Śmiech, Anna Wyszogrodzka-Kucharska, Dominik Strzelecki
Farmakoterapia w Psychiatrii i Neurologii, 2004, 3, 367-375